Cargando…
Modulating gut immunity and neoplasia with oral cytokine adjuvants
Oral administration of particulate IL-10 suppressed polyposis, ameliorated systemic pathology and extended lifespan in APC(min/+) mice. Therapeutic effect was associated with selective activity of IL-10 on intestinal CD4+Foxp3+RORγt+IL-17+ pathogenic T-regulatory cells. Studies were recently extende...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485710/ https://www.ncbi.nlm.nih.gov/pubmed/26137401 http://dx.doi.org/10.1080/2162402X.2014.1002724 |
_version_ | 1782378811236548608 |
---|---|
author | Ozbilge, Hatice LeVea, Charles Chung, Allen Y Li, Qingsheng Egilmez, Nejat K |
author_facet | Ozbilge, Hatice LeVea, Charles Chung, Allen Y Li, Qingsheng Egilmez, Nejat K |
author_sort | Ozbilge, Hatice |
collection | PubMed |
description | Oral administration of particulate IL-10 suppressed polyposis, ameliorated systemic pathology and extended lifespan in APC(min/+) mice. Therapeutic effect was associated with selective activity of IL-10 on intestinal CD4+Foxp3+RORγt+IL-17+ pathogenic T-regulatory cells. Studies were recently extended to a bacterially-driven murine colon adenocarcinoma model with similar results. Clinical implications of these findings are discussed. |
format | Online Article Text |
id | pubmed-4485710 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-44857102016-01-22 Modulating gut immunity and neoplasia with oral cytokine adjuvants Ozbilge, Hatice LeVea, Charles Chung, Allen Y Li, Qingsheng Egilmez, Nejat K Oncoimmunology Author's View Oral administration of particulate IL-10 suppressed polyposis, ameliorated systemic pathology and extended lifespan in APC(min/+) mice. Therapeutic effect was associated with selective activity of IL-10 on intestinal CD4+Foxp3+RORγt+IL-17+ pathogenic T-regulatory cells. Studies were recently extended to a bacterially-driven murine colon adenocarcinoma model with similar results. Clinical implications of these findings are discussed. Taylor & Francis 2015-01-22 /pmc/articles/PMC4485710/ /pubmed/26137401 http://dx.doi.org/10.1080/2162402X.2014.1002724 Text en © 2015 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted. |
spellingShingle | Author's View Ozbilge, Hatice LeVea, Charles Chung, Allen Y Li, Qingsheng Egilmez, Nejat K Modulating gut immunity and neoplasia with oral cytokine adjuvants |
title | Modulating gut immunity and neoplasia with oral cytokine adjuvants |
title_full | Modulating gut immunity and neoplasia with oral cytokine adjuvants |
title_fullStr | Modulating gut immunity and neoplasia with oral cytokine adjuvants |
title_full_unstemmed | Modulating gut immunity and neoplasia with oral cytokine adjuvants |
title_short | Modulating gut immunity and neoplasia with oral cytokine adjuvants |
title_sort | modulating gut immunity and neoplasia with oral cytokine adjuvants |
topic | Author's View |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485710/ https://www.ncbi.nlm.nih.gov/pubmed/26137401 http://dx.doi.org/10.1080/2162402X.2014.1002724 |
work_keys_str_mv | AT ozbilgehatice modulatinggutimmunityandneoplasiawithoralcytokineadjuvants AT leveacharles modulatinggutimmunityandneoplasiawithoralcytokineadjuvants AT chungalleny modulatinggutimmunityandneoplasiawithoralcytokineadjuvants AT liqingsheng modulatinggutimmunityandneoplasiawithoralcytokineadjuvants AT egilmeznejatk modulatinggutimmunityandneoplasiawithoralcytokineadjuvants |